Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
No open-market purchases or sales by Protara Therapeutics, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Protara Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 38 | 2 | 35 | −1 |
| Shares | 10.4M | 418.0K | 10.4M | +415.9K (+4.1%) |
| Value | $22.2M | $869.5K | $19.1M | −$2.25M (−10.5%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Protara Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 116,977 | $214.1K | 0.00% |
| XTX Topco Ltd | 32,682 | $59.8K | 0.00% |
| Millennium Management LLC | 14,402 | $26.4K | 0.00% |
| UBS Group AG | 7,418 | $13.6K | 0.00% |
| Semmax Financial Advisors Inc. | 1,572 | $4.06K | 0.00% |
| Simplex Trading, LLC | 373 | $0 | 0.00% |
Sold out (7)
Institutions that held Protara Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Armistice Capital, LLC | 520,000 | $1.08M |
| Privium Fund Management (UK) Ltd | 114,708 | $232.9K |
| Jane Street Group, LLC | 12,850 | $26.7K |
| Susquehanna International Group, LLP | 10,036 | $20.9K |
| Group One Trading, L.P. | 2,550 | $5.30K |
| Wells Fargo & Company | 500 | $1.04K |
| Qube Research & Technologies Ltd | 2 | $4 |
Not filed for Q3 2024 yet (2)
Institutions that held Protara Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| CVI Holdings, LLC | 302,746 | $629.7K |
| BlackRock Inc. | 115,273 | $239.8K |